Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NephroGenex (NRX) Stock Skyrockets On Positive Data From Cardiac Safety Study Of Pyridorin
NephroGenex (NRX) Stock Skyrockets On Positive Data From Cardiac Safety Study Of Pyridorin
NephroGenex (NRX) Stock Skyrockets On Positive Data From Cardiac Safety Study Of Pyridorin
Submitted by
admin
on January 2, 2015 - 7:38pm
Source:
Bidness Etc.
News Tags:
NephroGenex
Pyridorin
diabetic nephropathy
Headline:
NephroGenex (NRX) Stock Skyrockets On Positive Data From Cardiac Safety Study Of Pyridorin
Do Not Allow Advertisers to Use My Personal information
